The participation of RUNX2 in signaling pathways associated with stem cell pluripotency suggests the participation of this TF in the differentiation of tumor stem cells (CSCs) towards tumor cells (CCs) in specific tissues. The gene discussed is RUNX2; the disease is neoplasm.